Clinical Study of autologous blood injection for the treatment of recurrent temporomandibular joint dislocation - Autologous blood injection for recurrent temporomandibular joint dislocation

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Oral and Maxillofacial Surgery0 sites20 target enrollmentMay 9, 2016

Overview

Phase: N/A
Intervention: Not specified
Conditions: Not specified
Sponsor: Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Oral and Maxillofacial Surgery
Enrollment: 20
Status: Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

May 9, 2016

End Date

May 9, 2023

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Oral and Maxillofacial Surgery

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1\) Inflammatory diseases of temporomandibular joint, such as rheumatoid arthritis, tuberculous arthritis. 2\) Evidence of tumor or tumor like lesion in the TMJ. 3\) Temporomandibular disorders caused by metabolic diseases, including crystal deposition diseases such as gout, pseudogout, or crystal arthritis. 4\) Intercurrent facial palsy. 5\) Serious concomitant systemic disorder, including malignant hypertension, history of severe cardiovascular diseases or cerebrovascular disorders within 6 months, hemorrhagic gastric ulcers, uncontrolled diabetes, apparent bleeding tendency. 6\) Under anticoagulant therapy. 7\) Suspicion for active infection. 8\) History of serious psychiatric illness or psychiatry illness under medical treatment. 9\) Others diagnosed as inapplicable cases by an investigator.